Partnering: VasoDynamics Signs a Long-term Partnership Agreement with Cambrex for the Supply of Active Pharmaceutical Ingredients. Gallery Partnering: VasoDynamics Signs a Long-term Partnership Agreement with Cambrex for the Supply of Active Pharmaceutical Ingredients. By Ibrahim|2025-12-05T12:23:34+00:00December 3rd, 2025|News, Fundraising| Read More
Regulatory: VasoDynamics is accepted for Parallel Scientific Advice Meeting with EMA-FDA Gallery Regulatory: VasoDynamics is accepted for Parallel Scientific Advice Meeting with EMA-FDA By Ibrahim|2025-11-28T15:22:19+00:00November 21st, 2025|News, Fundraising| Read More
NG13-2 Clinical Study: MHRA Scientific Advisory Meeting on Clinical Study Design and Approval Path Gallery NG13-2 Clinical Study: MHRA Scientific Advisory Meeting on Clinical Study Design and Approval Path By Ibrahim|2025-11-28T15:21:38+00:00September 18th, 2025|News, NG13| Read More
Setting Footprint in Europe: VasoDynamics setting up VDL Pharma B.V. in Leiden Bioscience Park, the Netherlands Gallery Setting Footprint in Europe: VasoDynamics setting up VDL Pharma B.V. in Leiden Bioscience Park, the Netherlands By Ibrahim|2025-11-28T15:20:44+00:00August 18th, 2025|Corporate Development, News| Read More
